Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Metformin + OCP in Obese Adolescents with PCOS
NCT00283816Phase 3Completed
- Sponsor
- University of Rochester
- Start
- Jan 2006
- Primary completion
- Jan 2008
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial of liquid metformin (Aspargo Labs) in polycystic ovary syndrome (PCOS) (2 arms), sponsored by University of Rochester. Primary endpoint: Reduction in Abdominal Fat as Measured by Waist Circumference at 24 weeks. Started Jan 2006; status: completed.
02
Drugs
liquid metformin (Aspargo Labs)
03
Conditions
polycystic ovary syndrome (PCOS)
Beyond the preview
Go deeper on NCT00283816.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00283816.